Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining 0.12% today. In the last week its performance is -0.13%, and 13.40% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 70.78, so today’s gain of 0.12% is a significant step towards its target price. The GAP today is therefore 0.31%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 108737.56, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 71.80%.
At the current price of 67.18, it has a dividend yield of 3.40%, and its target price is 70.78. This is with a profit margin of 23.10%, and total debt/equity of 6.71. AbbVie Inc. (NYSE:ABBV) has a P/E of 19.24, as well as a forward P/E of 11.79.
With a current EPS of 3.49, and a forecasted EPS growth for next year at 18.53%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.28%.
Performance for the year is 3.28%. Since its IPO date on 1/2/2013, the total performance to date is 16.57%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 3452828, while its average volume is 7964.55. Whilst the total gain today was 0.12%, it did have a day high of -1.38%.
Volatility for this week has been at 1.34%, and 1.28% for the month. The 52-week low for AbbVie Inc., ABBV has been 52.12%, while the 52-week-high has reached -1.38%.
Looking at its return of investments, which is 16.90%, and its return on assets is 10.00%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 35.00%. With a sales growth of 17.80% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 6.62, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.18, and the P/S is 4.39, along with a P/B of 19.34. Meanwhile it has a p/cash of 13.59.